Financials
Financial year 2025
KINECURE KINESITHERAPIE from Genk, company number BE0748946007, closed financial year 2025 with a result of € 46,052 after tax. For that financial year KINECURE KINESITHERAPIE recorded a gross margin of € 76,143 and equity of € 184,018. Compared with financial year 2024, the result moved from € 39,479 to € 46,052. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 184,018
▲ 33% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 46,052
▲ 17% vs 2024
Profit after tax over the fiscal year.
€ 92,591
▲ 74% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 179,018.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,304
▼ 22% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,191
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 33,221 | € 65,551 | € 58,772 | € 76,143 | ▲ 30% |
| Profit after taxes | € 14,319 | € 40,629 | € 39,479 | € 46,052 | ▲ 17% |
| Equity | € 57,858 | € 98,486 | € 137,966 | € 184,018 | ▲ 33% |
| Total debts | € 9,195 | € 17,135 | € 5,227 | € 23,708 | ▲ € 18,481 |
| Cash | € 37,173 | € 107,420 | € 53,220 | € 92,591 | ▲ 74% |
| Land & buildings | - | € 1,193 | € 48,812 | € 72,454 | ▲ 48% |
| Retained profit | € 52,858 | € 93,486 | € 132,966 | € 179,018 | ▲ 35% |
| Balance sheet total | € 67,053 | € 115,621 | € 143,192 | € 207,726 | ▲ 45% |
Key figures of KINECURE KINESITHERAPIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about KINECURE KINESITHERAPIE the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to KINECURE KINESITHERAPIE?
What happened at KINECURE KINESITHERAPIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 46,052 (▲ 17% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Dilsen-Stokkem. KBO
- New establishment in Genk. KBO
- Dorien De Winter became a director. NBB
- Jan Geusens became a director. NBB
In short
From € 14,319 profit in 2022 to € 46,052 profit in 2025.
Paid € 58,395 in corporate taxes since 2022.
Best year ever: 2025, with € 46,052 profit.
Management
Behind KINECURE KINESITHERAPIE are Dorien De Winter and Jan Geusens.
Directors
According to the 2025 annual accounts
Dorien De Winter
Administrator-manager
since 2020
Jan Geusens
Administrator-manager
since 2020
Establishments
Establishment units
Physical locations of this company
Meeënheide 122
3600 Genk
Vlessersweg 28
3650 Dilsen-Stokkem
Active since 25 June 2020
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- GEUSENS Jan Michiel(oprichter) 50%
- DE WINTER Dorien(oprichter) 50%
Details
- Company number
- 0748.946.007
- VAT number
- BE 0748.946.007
- Registered office
- Meeënheide 122, 3600 Genk
- Names & denominations
- KINECURE KINESITHERAPIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 June 2020
- Peppol
- Active · Active since 30 Dec 2025